Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 189

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 189
---
. For these purposes (i) if the rights offering is for securities convertible into or exercisable for shares of ParentCo Common Stock, in determining the price payable for ParentCo Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of shares of ParentCo Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the ParentCo Common Stock trades on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of ParentCo Common Stock on account of such ParentCo Common Stock (or other securities into which the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends, (c) to satisfy the redemption rights of the holders of ParentCo Common Stock in connection with a proposed initial business combination, or (d) in connection with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of ParentCo Common Stock in respect of such event.

If the number of outstanding shares of ParentCo Common Stock is decreased by a consolidation, combination, reverse share split or reclassification of ParentCo Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of shares of ParentCo Common Stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding share of ParentCo Common Stock.

Whenever the number of shares of ParentCo Common Stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of ParentCo Common Stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of ParentCo Common Stock so purchasable immediately thereafter.

In case of any reclassification or reorganization